에어디바이버

In situations where medical personnel are scarce, such as battlefields or disaster sites, injured individuals often lose their lives because they do not receive timely emergency medication. Existing syringes carry the risk of infection due to needle use, and require trained personnel for accurate administration.

Although auto-injectors (such as EpiPen) and existing jet injectors exist, most require electric batteries or are limited to small devices for cosmetic purposes, making them **difficult to use universally in the field**. Additionally, while military self-injection kits exist, they are specialized for one type of drug, making it difficult to administer various medications depending on the situation.

Against this backdrop,AirDiverwas designed to allow anyone to quickly inject various types of emergency medications without electricity, aiming to solve the problem of increasing survival rates in disaster situations.

AirDiver is fully manually operated by a spring, requiring absolutely no power supply. Unlike existing jet injectors that mainly use electric motors or explosive power and are primarily limited to cosmetic/small-dose vaccine applications, AirDiver operates reliably even in the harsh conditions of war and disaster sites with its durable spring piston.

Furthermore, the needle-less technology eliminates the risk of cross-infection or invasive wounds by spraying drugs onto the skin at high pressure without needles.

The biggest differentiator is the rotary dial on top of the device, which allows users to select from 3 types of ampoules (nutrients, analgesics, infection preventatives, etc.). Users can select the necessary drug by turning the dial and inject it immediately, enabling one device to respond to multiple situations. This modular multi-drug injection function and intuitive operation are innovations not found in competing products.

As a result, it is a unique solution that allows even non-experts to perform immediate emergency treatment without power, needles, or complicated procedures.

This product has a strong B2B/B2G nature, and the main adopters will be the military, disaster relief organizations, and emergency medical groups. For example, the military medical system can distribute it to individual combatants for use as a self-emergency treatment kit, and the Red Cross or international relief organizations can supply it to rescue teams deployed to disaster sites. In terms of public health, it can also be stockpiled by the government as a disaster preparedness item.

Although general consumers (B2C) are unlikely to purchase it directly, there may be special demand from mountain explorers or preppers. Basically, it will be in the form of mass purchases through companies and governments, and organizations related to life-saving will be the ones paying for it (B2G: defense/security agencies, B2B: industrial safety teams, etc.).

AirDiver can be applied to any environment with insufficient medical infrastructure, making it widely applicable. In addition to pre-hospital emergency care, it may also be useful in special environments such as future spaceflight or polar exploration.

However, there is the challenge of passing medical device regulations. It currently appears to be in the concept stage, and commercialization will take time as it must be certified by the FDA in each country.

Technically, it can also be applied to other drug types (e.g., insulin administration), and if development continues, it can be expanded to emergency kits for patients with chronic diseases. In addition, it is designed with a modular replacement system, so there is plenty of room for improvement, such as adding more than 3 types of drug packs or adding a pressure adjustment function to suit various skin thicknesses/ages.

In summary, although the primary use is a clear niche, the social value of the product concept is high, so there is a high possibility of government support, and it can be quickly scaled to the international relief market once certification is secured.

Selected as an Innovation Award winner in the Technology in Support of Human Security for All category at CES 2026, it was recognized as a public interest innovation that contributes to saving lives. The judges praised the *"simple mechanical solution to the medical gap problem"*, especially the power-free manual operation and safety.

This product was also selected as an international Top20 project at the 2025 James Dyson Award, recognizing its design completeness and social impact.

However, it is currently in the prototype/student team project stage, so the technology readiness level (TRL) is low. Critics point out that *"the concept is excellent, but actual field testing and durability verification are needed"*, and that additional development and investment are important for commercialization. Nevertheless, it is an example of *"the power of ideas over technology"*, and is receiving encouragement and attention rather than being underestimated.

Overall, the market has a positive view that *"it touches on a niche but essential problem,"* and there are rumors that defense and disaster industries are contacting them as a result of winning the CES award.